Currently, AD can be diagnosed at the mild cognitive impairment (MCI) and even cognitively unimpaired stage with positive amyloid and tau biomarkers, however when patients at the MCI stage will convert to dementia is still unclear. Here, MAPT is linked to Alzheimer disease.